Request Sample Inquiry
Glaucoma Medications Market

Glaucoma Medications Market

Glaucoma Medications Market Global Industry Assessment & Forecast

img
Healthcare
# Pages:

142

Base Year:

2021

Nov - 2021

Format:

Report Code:

VMR-2021-0522

Segments Covered
  • By Indication Open Angle Glaucoma, Closed Angle Glaucoma, Secondary Glaucoma, Congenital Glaucoma, Others
  • By Drug Class Prostaglandin Analogs, Beta Blockers, Alpha Agonist, Carbonic Anhydrase Inhibitors, Others
Snapshot
Forecast YearsForecast Years: 2021 - 2028
Historical YearsHistorical Years: 2016 - 2020
Revenue 2021Revenue 2021: 7.51 Billion
Revenue 2028Revenue 2028: 10.76 Billion
Revenue CAGRRevenue CAGR (2021 - 2028): 4.6
Fastest Growing Region Fastest Growing Region (2022 - 2028) North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report
  • Go To Market Strategy
  • Region Specific Market Dynamics
  • Region Level Market Share
  • Import Export Analysis
  • Production Analysis
  • Others Request Customization Speak To Analyst

Table of Content:

  1. Chapter No. 1: Introduction
    1. Report Scope
    2. Objectives of the Study
    3. USP & Key Offerings
    4. Target Audience
    5. Vantage Market Research Report Guidance/Walk-through
  2. Chapter No. 2: Premium Insights
    1. Market Snapshot
    2. Top Investment Pockets
      1. Market Attractiveness Analysis, By Indication
      2. Market Attractiveness Analysis, By Drug Class
      3. Market Attractiveness Analysis, By North America
    3. Insights from Primary Respondents
  3. Chapter No. 3: Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter’s Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
    10. Pricing Analysis
    11. Patent Analysis
    12. Value Chain Analysis
    13. Downstream Buyers
    14. Distributors/Traders List
  4. Chapter No. 4: Competitive Landscape
    1. Competition Matrix – 2020
    2. Company Market Share Analysis – 2020
      1. Company Market Share, 2020
      2. Company Market Revenue, 2017 – 2020 (USD Million)
      3. Company Y-o-Y Growth, 2018 – 2020 (%)
    3. Strategic Developments
      1. CAcquisitions & Mergers
      2. New Product Launch
      3. New Product Launch
    4. New Product Launch
  5. Chapter No. 5: COVID 19 Impact Analysis
    1. Impact Assessment of COVID-19 Pandemic, By North America
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    2. Quarterly Market Revenue Forecast by North America 2020 & 2021
    3. Pre COVID-19 Market Revenue, By North America, 2016-2019 (USD Million)
    4. Post COVID-19 Market Revenue, By North America, 2020-2028 (USD Million)
    5. Key Strategies Undertaken by Companies to Tackle COVID-19
    6. Short Term Dynamics
    7. Long Term Dynamics
  6. Chapter No. 6: Global Glaucoma Medications Market - Segment Analysis
    1. Overview
    2. Global Glaucoma Medications Market, 2016 – 2028 (USD Million)
      1. Global Market Revenue, By North America, 2020 & 2028
    3. Global Market Revenue, By North America, 2020 & 2028
      1. Global Market Revenue, By North America, 2020 & 2028
    4. Global Keyword Market - By Drug Class
      1. Overview
    5. Global Keyword Market - By North America
      1. Overview
      2. Global Market Revenue, By North America, 2016 – 2028 (USD Million)
  7. Chapter No. 7: North America Glaucoma Medications Market - Segment Analysis
    1. Overview
    2. North America Glaucoma Medications Market, 2016 – 2028 (USD Million)
    3. North America Market, By Indication
      1. North America Market Revenue, By Indication, 2016 – 2028
    4. North America Market, By Drug Class
      1. North America Market Revenue, By Drug Class, 2016 – 2028
    5. North America Market, By
      1. North America Market Revenue, By , 2016 – 2028 (USD Million)
  8. Chapter No. 8: Europe Glaucoma Medications Market - Segment Analysis
    1. Overview
    2. Europe Glaucoma Medications Market, 2016 – 2028 (USD Million)
      1. Europe Market Revenue Share, By , 2020 & 2028
    3. Europe Market, By Indication
      1. Europe Market Revenue, By Indication, 2016 – 2028
    4. Europe Market, By Drug Class
      1. Europe Market Revenue, By Drug Class, 2016 – 2028
    5. Europe Market, By
      1. Europe Market Revenue, By , 2016 – 2028 (USD Million)
  9. Chapter No. 9: Asia Pacific Glaucoma Medications Market - Segment Analysis
    1. Overview
    2. Asia Pacific Glaucoma Medications Market, 2016 – 2028 (USD Million)
      1. Asia Pacific Market Revenue Share, By , 2020 & 2028
    3. Asia Pacific Market, By Indication
      1. Asia Pacific Market Revenue, By Indication, 2016 – 2028
    4. Asia Pacific Market, By Drug Class
      1. Asia Pacific Market Revenue, By Drug Class, 2016 – 2028
    5. Asia Pacific Market, By
      1. Asia Pacific Market Revenue, By , 2016 – 2028 (USD Million)
  10. Chapter No. 10: Latin America Glaucoma Medications Market - Segment Analysis
    1. Overview
    2. Latin America Glaucoma Medications Market, 2016 – 2028 (USD Million)
      1. Latin America Market Revenue Share, By , 2020 & 2028
    3. Latin America Market, By Indication
      1. Latin America Market Revenue, By Indication, 2016 – 2028
    4. Latin America Market, By Drug Class
      1. Latin America Market Revenue, By Drug Class, 2016 – 2028
    5. Latin America Market, By
      1. Latin America Market Revenue, By , 2016 – 2028 (USD Million)
  11. Chapter No. 11: Middle East & Africa Glaucoma Medications Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Glaucoma Medications Market, 2016 – 2028 (USD Million)
      1. Middle East & Africa Market Revenue Share, By , 2020 & 2028
    3. Middle East & Africa Market, By Indication
      1. Middle East & Africa Market Revenue, By Indication, 2016 – 2028
    4. Middle East & Africa Market, By Drug Class
      1. Middle East & Africa Market Revenue, By Drug Class, 2016 – 2028
    5. Middle East & Africa Market, By
      1. Middle East & Africa Market Revenue, By , 2016 – 2028 (USD Million)
  12. Chapter No. 12: Marketing Strategy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
    5. Economic/Political Environmental Change
  13. Chapter No. 13: Company Profiles
    1. Company
  14. Chapter No. 14: Research Methodology
    1. Research Methodology
    2. Phase I - Secondary Research
    3. Phase II - Data Modeling
      1. Company Share Analysis Model
      2. Revenue Based Modeling
    4. Phase III - Primary Research
    5. Research Limitations
      1. Research Limitations
FAQ
Frequently Asked Question

  • The global Glaucoma Medications valued at 7.51 Billion in 2020 and is expected to reach 10.76 Billion in 2028 growing at a CAGR of 4.6%.

  • The prominent players in the market are Laboratoires Thea, Actavis, APOTEX, GE Medical, Mylan, Taj Pharmaceuticals, Teva Pharmaceutical, Jamp Pharma, Greenstone, Mint Pharmaceuticals, SANDOZ, Bausch + Lomb, Fresenius, Sun Pharma, Laboratoire Riva, Pfizer, Novartis..

  • The market is project to grow at a CAGR of 4.6% between 2021 and 2028.

  • The driving factors of the Glaucoma Medications include

    • The rising cases of glaucoma across the globe and new drug developments are expected to fuel the growth of the market during the forecast period.
    • The technological advancement in treatment of glaucoma, and various pharmaceutical and biotechnological companies are investing in new product development for glaucoma is a factor driving the market.

  • North America was the leading regional segment of the Glaucoma Medications in 2020.

We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies Privacy Policy